Update on Triple Negative Breast Cancer
also plays a critical role in TNBC. Furthermore, targeting host immune system using immune checkpoint blockade agents have been recently shown to have promising durable responses in several patients with
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
also plays a critical role in TNBC. Furthermore, targeting host immune system using immune checkpoint blockade agents have been recently shown to have promising durable responses in several patients with
clinical benefit. The limited applicability and efficacy of checkpoint blockade drugs is due to the requirement for a pre-existing, effective immune response to be resident within the tumor lesions ... tumors) in order…
Immune checkpoint inhibitors (ICIs) have revolutionized therapeutic strategies in both oncology and
been identified as critical players in hepatocellular carcinoma promotion and even modulate the immune-mediated checkpoint blockade. These can be targeted by nutrients, immunologically active, modulating the plasticity…
been identified as critical players in hepatocellular carcinoma promotion and even modulate the immune-mediated checkpoint blockade. These can be targeted by nutrients, immunologically active, modulating the plasticity…
Blockade of the immune checkpoints has recently emerged as a paradigm shift in the treatment of solid tumors. Several programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte ... combination with monoclonal…
As the use of immune checkpoint inhibitors in cancer therapy increases across
therapeutic advancements. Research covers single-cell atlases of kidney immunity [1], the evolution of cancer immunotherapies including checkpoint blockade and cell engineering [2,4], and the molecular mechanisms…
pembrolizumab have been approved for treatment of advanced melanoma. As checkpoint blockade is associated with potentially serious immune-related adverse events, including autoimmune hepatitis, clinical trials…
cell responses, and their blockade can restore anti-tumor immunity. Challenges include tumor microenvironment modulation, resistance mechanisms, and the need for better predictive biomarkers. Emerging checkpoints and…
response to a T-dependent (TD) or a Tindependent (TI) antigen immunization with concomitant administration of either checkpoint inhibitors such as antibodies to CTLA ... Results: We found that checkpoint blockade with…
The field of hepatocellular carcinoma (HCC) immunotherapy has made progress whereas negative
Anti-tumor immunity is enhanced by binding programmed cell death protein 1 and programmed cell death ligand 1.Cytotoxic drugs are considered as potential partners in blockade of checkpoints. More interest
anti-tumor response. CD200 acts as a checkpoint blockade when engaging its receptor CD200R. CD200 upregulates peptidylprolyl isomerase A (PPIA), resulting in immune suppression. CD200 is expressed on endothelial cells
Molecules directed against immune checkpoints and other agonists show great promise for treatment of a variety of malignancies. Next to CTLA-4 and PD-1 blockade, a wide range ... combination therapies can be done using…
antitumor response. CD200 acts as a checkpoint blockade when engaging its receptor CD200R. CD200 up-regulates peptidylprolyl isomerase A (PPIA), resulting in immune suppression. CD200 is expressed on endothelial cells
VISTA) is a novel negative checkpoint ligand that suppresses T-cell mediated immune responses. Previous studies using VISTA-neutralizing monoclonal antibody show that VISTA-blockade enhances T cell-activation ... aged…
major mechanisms of immune escaping exerted by several cancer types in which up-regulation of PDL1 is observed. The success of checkpoint blockade therapy in the treatment of different solid
major mechanisms of immune escaping exerted by several cancer types in which up-regulation of PDL1 is observed. The success of checkpoint blockade therapy in the treatment of different solid
focused on enhancing T-cell responses: whether it is unleashing T cells through blockade of regulatory checkpoint inhibitors or generation of chimeric antigen receptor (CAR) T cells. However, there ... need for better…
focused on enhancing T-cell responses: whether it is unleashing T cells through blockade of regulatory checkpoint inhibitors or generation of chimeric antigen receptor (CAR) T cells. However, there ... need for better…
treatment. Therefore, combined checkpoint blockade with nivolumab 1 mg/kg and ipilimumab 3 mg/kg (NIVO1+IPI3) is frequently used despite low response rates and high immune-related toxicity. There
programmed cell death receptor 1 (PD-1) (PD-L1/PD-1) immune checkpoint pathway. In this study we demonstrate that PIT can be augmented by PD-L1 knockdown ... induced cancer immunotherapy are more effective when combined…
being detected or eliminated by immune cells. Immune checkpoints refer to a network of stimulatory or inhibitory signaling pathways in the immune system which are critical in maintaining self-tolerance ... therapeutic…
immune system in the fight against cancer. Basic science discoveries elucidating the molecular and cellular biology of the T cell have led to new strategies in this fight, including checkpoint ... blockade, adoptive…
For authors and organisers
Find the right journal for your paper and submit your manuscript.